For over twenty five years, Chris has worked at the intersection of science, strategy, and finance within the life sciences sector. Transitioning from laboratory research to equity analysis, investment banking, and company building, he brings deep insight into how innovation is financed, developed, and commercialized. He was ranked the UK’s number one healthcare analyst and co founded a specialist investment banking boutique later acquired by a global firm. He later founded Aruwon, advising startups and investors on financing, licensing, and partnerships. Today, Chris provides operational leadership for SMEs, combining scientific rigor, financial discipline, and governance to guide innovation to market.